The Centre for Surgical Invention and Innovation
The Centre for Surgical Invention and Innovation (CSii) is a National Centre of Excellence research accelerator committed to enhancing the quality and access to healthcare for all Canadians through the development and commercialization of innovative medical robotic technologies and novel techniques. CSii is leveraging Canadian expertise in minimal access surgery and space technology to build a legacy industry that will create high tech jobs, strengthen the economy and create better medical outcomes.
IGAR in the News
An image-guided automated robot from MRI breast biopsy in THE INTERNATIONAL JOURNAL OF MEDICAL ROBOTICS AND COMPUTER ASSISTED SURGERY Int J Med Robotics Comput Assist Surg 2016 Published online in Wiley Online Library (wileyonlinelibrary.com) DOI; 10.1002/res.1760 ORIGINAL ARTICLE
NASA ISS R&D 2015 Innovation Award - Presented to Dr. Mehran Anvari, July 7, 2015, Boston, Massachusetts.
Dr. Mehran Anvari was presented with an award for innovation in Biology and Medicine for his work with Image-Guided Automated Robot (IGAR) at the NASA -International Space Station Research and Development Awards, Boston, Massachusetts. “This is a nice recognition of almost 20 years of work,” said Anvari. “It recognizes an incredible team of talented people including engineers, technicians, doctors and astronauts who have helped develop this technology. We believe this technology will improve efficiency in the health care system by streamlining clinical workflow and allowing highly-skilled radiologists to extend their care to a wider population through teleoperation.”
Canadian Space Agency
CBC's The National, Remarkable Canadarm, "Technology is being deployed for Breast Cancer Surgery"
Hamilton's CHCH TV, "October means Breast Cancer Awareness Month"
IGAR Breast System: MRI Breast Biopsy and Ablation
The CSii Image Guided Automated Robot (IGAR) is designed for use in the early detection and treatment of breast cancer. With regulatory clearance the first IGAR robotic system will have four key product features; biopsy, ablation treatment, tele-operation, and seed placement/insertion.
The system is designed to offer one stop diagnosis and treatment for patients with high risk of breast cancer.